- Home
- SMTI vs RZLT Comparison
SMTI vs RZLT Comparison
Compare SMTI & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- RZLT
- Stock Information
- Founded
- SMTI 1982
- RZLT 2010
- Country
- SMTI United States
- RZLT United States
- Employees
- SMTI N/A
- RZLT N/A
- Industry
- SMTI Medical/Dental Instruments
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- SMTI Health Care
- RZLT Health Care
- Exchange
- SMTI Nasdaq
- RZLT Nasdaq
- Market Cap
- SMTI 251.6M
- RZLT 819.3M
- IPO Year
- SMTI N/A
- RZLT N/A
- Fundamental
- Price
- SMTI $31.42
- RZLT $9.19
- Analyst Decision
- SMTI Strong Buy
- RZLT Strong Buy
- Analyst Count
- SMTI 2
- RZLT 6
- Target Price
- SMTI $50.00
- RZLT $14.50
- AVG Volume (30 Days)
- SMTI 25.8K
- RZLT 1.6M
- Earning Date
- SMTI 11-12-2025
- RZLT 11-07-2025
- Dividend Yield
- SMTI N/A
- RZLT N/A
- EPS Growth
- SMTI N/A
- RZLT N/A
- EPS
- SMTI N/A
- RZLT N/A
- Revenue
- SMTI $97,241,894.00
- RZLT N/A
- Revenue This Year
- SMTI $24.49
- RZLT N/A
- Revenue Next Year
- SMTI $14.43
- RZLT N/A
- P/E Ratio
- SMTI N/A
- RZLT N/A
- Revenue Growth
- SMTI 34.29
- RZLT N/A
- 52 Week Low
- SMTI $23.53
- RZLT $2.22
- 52 Week High
- SMTI $39.08
- RZLT $10.04
- Technical
- Relative Strength Index (RSI)
- SMTI 52.67
- RZLT 56.61
- Support Level
- SMTI $28.81
- RZLT $8.70
- Resistance Level
- SMTI $31.35
- RZLT $9.89
- Average True Range (ATR)
- SMTI 1.52
- RZLT 0.57
- MACD
- SMTI 0.08
- RZLT -0.01
- Stochastic Oscillator
- SMTI 47.79
- RZLT 66.91
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.